The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly

Vaccine

Volumn 14, Issue 16, 1996, Pages 1531-1537

  Evans, Thomas G ^a   Judd, Michael E ^a   Dowell, Tad ^b   Poe, Samantha ^a   Daynes, Raymond A ^c   Araneo, Barbara A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Paradigm Biosciences Inc   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Dehydroepiandrosterone; Immunosenescence

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; PRASTERONE SULFATE; TETANUS TOXOID;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLUENZA; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DEHYDROEPIANDROSTERONE SULFATE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; TETANUS TOXOID;

EID: 0030293905     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00095-3     Document Type: Article

References (49)

1. 1 Miller, R.A. Minireview. The cell biology of aging: immunological models. J. Geront. 1989, 44, B4-B8
2. 2 Thoman, M.L. and Weigle, W.O. Lymphokines and aging: interleukin-2 production and activity in aged animals. J. Immun. 1981, 127, 2101-2106
3. 3 Nagel, J.E., Chopra, R.K., Chrest, F.J. et al. Decreased proliferation, interleukin 2 synthesis and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. clin. Invest. 1988, 81, 1096-2002
4. 4 Birkenhäger-Gillesse, E.G., Derksen, J. and Lagaay, A.M. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann. N.Y. Acad. Sci. 1994, 719, 543-545
5. 5 Carlström, K., Brody, S., Lunell, N.-O. et al. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitus 1988, 10, 297-306
6. 6 Migeon, C.J., Keller, A.R., Lawrence, B. and Shepard, T.H. Dehydroepiandrosterone and androsterone levels in human plasma, effect of age and sex: day-to-day and diumal variations. J. clin. Endocrin. Metab. 1957, 17, 1051-1062
7. 7 Daynes, R.A. and Araneo, B.A. Prevention and reversal of age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging: Immun. Infect. Dis. 1992, 3, 135-154
8. 8 Daynes, R.A., Araneo, B.A., Ershler, W.B. et al. Altered regulation of, IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immun. 1993, 150, 5219-5230
9. 9 Daynes, R.A., Dudley, D.J. and Araneo, B.A. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T cells. Eur. J. Immun. 1990, 20, 793-802
10. 10 Daynes, R.A. and Araneo, B.A. Natural regulators of T-Cell lymphokine production in vivo. J. Immunother. 1992, 12, 174-179
11. 11 Daynes, R.A. and Araneo, B.A. Programming of lymphocyte responses to activation: extrinsic factors, provided microenvironmentally, confer flexibility and compartmentalization to T-cell function. Chem. Immun. 1992, 54, 1-20
12. 12 Suzuki, T., Suzuki, N., Daynes, R.A. and Engleman, E.G. Dehydroepiandrosterone enhances, IL-2 production and cytotoxic effector function of human T-cells. Clin. Immun. Immunopath. 1991, 61, 202-211
13. 13 Morales, A.J., Nolan, J.J., Nelson, J.C. and Yen, S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrin. Metab. 1994, 78, 1360-1367
14. 14 Barrett-Connor, E. and Edelstein, S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. JAGS 1994, 42, 420-423
15. 15 Mortola, J. and Yen, S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J. clin. Endocrin. Metab. 1990, 71, 696-704
16. 16 Dyner, T.S., Lang, W., Geaga, J. et al. An open-label dose escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J. Acquired Immune Defic. Syn. 1993, 6, 459-465
17. 17 Araneo, B.A., Woods, M.L. and Daynes, R.A. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J. Infect. Dis. 1993, 167, 830-840
18. 18 Daynes, R.A. and Araneo, B.A. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Ann. N.Y. Acad. Sci. 1994, 730, 144-161
19. 19 Danenberg, H.D., Ben-Yehuda, A.B., Zakay-Rones, Z. et al. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995, 13, 1445-1448
20. 20 General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 1994, 43(RR-I), 1-38
21. 21 Guide for Adult Immunizations. American College of Physicians, Philadelphia, PA, 1994, pp. 90-97, 130-134
22. 22 Williams, W.W., Hickson, M.A., Kane, M.A. et al. Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann. Intern. Med. 1988, 108, 616-625
23. 23 Weiss, B.P., Strassburg, M.A. and Feeley, J.C. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am. J. Publ. Hlth 1983, 73, 802-804
24. 24 Gergen, P.J., McQuillan, G.M., Kiely, M., Ezzati-Rice, T.M., Sutter, R.W. and Virella, G. A population-based serologic survey of immunity to tetanus in the United States. N. Engl. J. Med. 1995, 332, 761-766
25. 25 Sanford, J.P. Tetanus - forgotten but not gone. N. Engl. J. Med. 1995, 322, 812-813
26. 26 Nolla-Salas, M. and Garcés-Brusés, J. Severity of tetanus in patients older than 80 years: comparative study with younger patients. Clin. Infect. Dis. 1993, 16, 591-592
27. 27 Richardson, J.P. Tetanus and tetanus immunizations in long-term care facilities. Infect. Control Hosp. Epidemiol. 1994, 14, 591-594
28. 28 Ershler, W.B., Moore, A.L. and Socinski, M.A. Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine. J. clin. Immun. 1984, 4, 445-454
29. 29 Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody response elicited by inactivated influenza virus vaccine. J. Infect. Dis. 1993, 167, 584-592
30. 30 Gross, P.A., Ennis, F.A., Gaerlan, P.F., Denson, L.J., Denning, C.R. and Schiffman, D. A controlled double blind comparison of reactogenicity and protective efficacy of whole virus and split product influenza vaccines in children. J. Infect. Dis. 1977, 136, 623-632
31. 31 Strassburg, M.A., Greenland, S., Sorvillo, F.J., Lieb, L.E. and Habel, L.A. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4, 38-44
32. 32 Melville-Smith, M.E., Seagroatt, V.A. and Watkins, J.T. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for estimation of tetanus antitoxin in human sera. J. biol. Stand. 1983, 11, 137-144
33. 33 Virella, G. and Hyman, B. Quantitation of anti-tetanus and anti-diphtheria antibodies by enzymoimmunoasssay: methodology and applications. J. clin. Lab. Anal. 1991, 5, 43-48
34. 34 Schmidt, N.J. and Emmons, R.W. Diagnostic Procedures for Viral, Rickettsial and Chlamydial, Infections, 6th edn. American, Public Health Association, Washington, DC, 1989
35. 35 Kishimoto, S., Tomino, S., Mitsuya, H., Fujiwara, H. and Tsuda, H. Age related decline in the in vitro and in vivo synthesis of anti-tetanus toxoid antibody in humans. J. Immun. 1980, 125, 2347-2352
36. 36 Yeni, P., Carbon, C., Tremolieres, F. and Gilbert, C. Serum levels of antibody to toxoid during tetanus and after specific immunization of patients with tetanus. J. Infect. Dis. 1982, 145, 278
37. 37 Ruben, F.L., Nagel, J. and Fireman, P. Antitoxin responses in the elderly to tetanus-diphtheria (Td) immunization. Am. J. Epidemiol. 1978, 108, 145-149
38. 38 Solomonova, K. and Vizev, S. Secondary response to boostering by purified aluminum-hydroxide-absorbed tetanus anatoxin in aging and in aged adults. Immunobiology 1981, 158, 312-319
39. 39 Simonsen, O., Block, A.V., Klaerke, A. et al. Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age. Surg. Gynec. Obstet. 1987, 164, 329-334
40. 40 Armitage, K.B., Duffy, E.G., Mincek, M.A. et al. Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J. Geront. 1993, 48, M19-M25
41. 41 Huang, Y.P., Gauthey, L., Michel, M. et al. The relationship between influenza vaccine-induced specific antibody responses and vaccine-induced nonspecific autoantibody responses in healthy older women. J. Geront. 1992, 47, M50-M55
42. 42 Beyer, W.E.P., Palache, A.M., Baljet, M. and Masurel, N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989, 7, 385-394
43. 43 Glathe, H., Bigl, S. and Groshe, A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Vaccine 1993, 11, 702-705
44. 44 Nestler, J.E., Barlascini, C.O., Clore, J.N. and Blackard, W.G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. clin. Endocrin. Metab. 1988, 66, 57-61
45. 45 Usiskin, K.S., Butterworth, S., Clore, J.N. et al. Lack of effect of DHEA in obese men. Int. J. Obesity 1990, 14, 457-463
46. 46 Welle, S., Jozefowicz, R., Statt, M. and Failure of, D.H. EA to influence energy and protein metabolism in humans. J. clin. Endocrin. Metab. 1990, 71, 1259-1264
47. 47 Ebeling, P. and Koivisto, V.A. Physiological importance of dehydroepiandrosterone. Lancet 1994, 343, 1479-1481
48. 48 Casson, P.R., Anderson, R.N., Herrod, H.G. et al. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynec. 1993, 169, 1536-1539
49. 49 Ershler, W.B. Influenza vaccination in the elderly: can efficacy be enhanced?. Geriatrics 1988, 43, 79-83